New Peer-Reviewed Study Leverages NeurOptics’ Automated Pupillometry to Measure Pupil Reactivity Differences, an Earlier Indicator of Neurological Injury
Retrieved on:
Wednesday, September 14, 2022
Research, Medical Devices, Neurology, Hospitals, Clinical Trials, Managed Care, Health, Optical, Science, Adult, Lists of diseases, Time, Traumatic brain injury, Cardiac arrest, Pupilometer, Twitter, Risk, Jean-Louis Vincent, Brain, NPI, DaiWai Olson, Neurosurgery, Knowledge, LinkedIn, Health, Stroke, University of Texas Southwestern Medical Center, Patient, Emergency medicine, Eye, Decision-making, Technology, Neurological pupil index, TBI, Doctor of Philosophy, Seizure, Science, BioMed Central, Neurology, Research, RN, Hospital, Multimedia, University, Rankine scale, Medical imaging, Pharmaceutical industry, Facebook
A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index (NPi) differential, measured by NeurOptics NPi Pupillometer, can be an early indicator of neurological injury.
Key Points:
- A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index (NPi) differential, measured by NeurOptics NPi Pupillometer, can be an early indicator of neurological injury.
- Automated pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
- Patients were assessed using NeurOptics automated pupillometer to objectively measure pupil size and reactivity, NPi, in each eye and calculate the NPi differential.
- NeurOptics quantitative automated pupillometer provides a reliable measurement of pupil size and reactivity and tracks changes over time, allowing for earlier intervention for patients with brain injury and those at risk of secondary neurological injury.